Sell Each Drug When Approved Rather than sell whole Company When PV-10 is approved.
It seems to me to maximize shareholder and management's return on PVCT drug development it would make a lot more sense to sell each drug separately. If the company is sold after PV-10 is approved the COO has said something to the effect of not selling for less than $2.9 Billion. Well, it that is true and with total O/S shares approaching 200M that would max out around $15/share........Where as if each drug is sold separately as approved the payoff would be several times greater.
When Pete quoted the $2.9 billion he was using that number from a different company as an example of how PVCT's deal might look like. It was more about the structure of the deal. If you were to contact Pete or any other member of MGT you will likely find the numbers they want to see being much higher. Hopefully by late Sunday night we get part two of the Blog's evaluation post. The numbers he has come up with are telling. Be looking for it.
I will and appreciate the info as very much. I have the link to the blog and am receiving reports.....good info
Thanks again guys......I am feeling good about the prospects and have expressed by a good size position for me....